Lifecore Biomedical 通过私募筹集了 $24.3M 用于营运资金和增长。 Lifecore Biomedical raises $24.3M through private placement for working capital and growth.

Lifecore Biomedical 通过私募融资获得了 2430 万美元，以每股 4.10 美元的价格向新老投资者出售了 5,928,775 股股票。 Lifecore Biomedical has secured $24.3 million through a private placement, selling 5,928,775 shares at $4.10 each to new and existing investors. 这些资金将支持周转资金、业务和公司目的,协助该公司在制药服务部门的增长。 The funds will support working capital, operations, and corporate purposes, aiding the company's growth in the pharmaceutical services sector. 首席执行官保罗·约瑟夫对投资者对管理团队的信心和该公司的未来前景表示赞赏。 CEO Paul Josephs expressed appreciation for investor confidence in the management team and the company's future prospects.